Skip to content
lsd.com

Utah

Psychedelic trials in Utah

23 registered trials has a study site in Utah, and 3 are recruiting now.

23
Trials with a site here
3
Recruiting
18
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 3lsd30
KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn InjuryNCT07563296 · Irma FlemingRecruitingPhase 2ketamine1
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean DeliveryNCT06767566 · University of UtahRecruitingPhase 1ketamine2

Facilities

Where the research happens in Utah

FacilityCityTrials
Cedar Clinical ResearchDraper10
Huntsman Cancer InstituteSalt Lake City3
Inner Space ResearchOrem2
University of Utah HealthSalt Lake City2
University of UtahSalt Lake City2
Inner Space Research, LLCOrem1
The University of Utah - Huntsman Mental Health InstituteSalt Lake City1
Cedar Clinical Research, Inc.Murray1
Clinical Site 117Murray1
Intermountain Medical CenterMurray1
McKay-Dee HospitalOgden1
Utah Valley HospitalProvo1
Primary Children's HospitalSalt Lake City1
Cedar Clinical Research - MurrayMurray1
University Of UtahSalt Lake City1
Clinical Site 147Draper1
Seelos Investigational SiteSalt Lake City1
Huntsman Mental Health InstituteSalt Lake City1

Stay told

When a trial opens in Utah

Research alerts

Get a notification when a trial for trials in Utah starts recruiting

This registry is rebuilt every week from the federal registry. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Utah site

TrialStatusPhaseSubstanceSites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 3lsd30
KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn InjuryNCT07563296 · Irma FlemingRecruitingPhase 2ketamine1
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean DeliveryNCT06767566 · University of UtahRecruitingPhase 1ketamine2
Comparative Effectiveness of ECT vs. KETAMINE Over the LifespanNCT06034821 · Brigham and Women's HospitalEnrolling by invitationPhase 4ketamine10
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"NCT06564818 · Cybin IRL LimitedActive, not recruitingPhase 3psilocybin45
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.Active, not recruitingPhase 3lsd34
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 · Definium Therapeutics US, Inc.Active, not recruitingPhase 3lsd22
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 · COMPASS PathwaysCompletedPhase 3psilocybin40
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 · COMPASS PathwaysActive, not recruitingPhase 3psilocybin116
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · Usona InstituteActive, not recruitingPhase 3psilocybin29
Endogenous Opioid Modulation by KetamineNCT03051945 · University of UtahWithdrawnPhase 3ketamine1
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)NCT06051721 · Cybin IRL LimitedCompletedPhase 2dmt6
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderNCT06340958 · Clexio Biosciences Ltd.CompletedPhase 2ketamine23
A Study of Psilocybin for Major Depressive Disorder (MDD)NCT03866174 · Usona InstituteCompletedPhase 2psilocybin11
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)NCT04772222 · University of UtahCompletedPhase 2dmt5
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 · Definium Therapeutics US, Inc.CompletedPhase 2lsd22
Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery EnhancementNCT07369089 · University of California, San DiegoNot yet recruitingPhase 2ketamine2
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd.CompletedPhase 2ketamine46
A Study of Ketamine in Patients With Treatment-resistant DepressionNCT01627782 · Janssen Research & Development, LLCCompletedPhase 2ketamine13
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of SuicideNCT04669665 · Seelos Therapeutics, Inc.CompletedPhase 2ketamine21
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related BurnoutNCT05557643 · University of UtahCompletedPhase 1psilocybin1
Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI CancersNCT06001372 · University of UtahTerminatedEarly Phase 1ketamine1
Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerNCT04522804 · University of UtahCompletedEarly Phase 1psilocybin1

Site locations from ClinicalTrials.gov API v2, data build 2026-10-06.

Elsewhere

Other states